Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Phase 3 Recruiting
1,100 enrolled
Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction
Phase 1/2 Completed
47 enrolled 7 charts
Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Phase 2 Completed
50 enrolled
NORA
Phase 2 Completed
68 enrolled 21 charts
DURATION
Phase 2 Completed
200 enrolled
Toco-Pulm
Phase 3 Terminated
79 enrolled
EPIC
Phase 3 Unknown
567 enrolled
Oral Navelbine and Cisplatin Followed by Metronomic Oral Navelbine in Non-Small Cell Lung Cancer
Phase 2 Terminated
45 enrolled
Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN)
Phase 2 Completed
42 enrolled 7 charts
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
Phase 1 Completed
18 enrolled
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
Phase 3 Terminated
34 enrolled 6 charts
Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation
Phase 3 Withdrawn
Vinorelbine in Treating Older Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 2 Completed
59 enrolled
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer
Phase NA Completed
25 enrolled 6 charts
Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung
Phase 2 Terminated
45 enrolled 4 charts
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
Phase NA Completed
6 enrolled 6 charts
Lung-TRIO
Phase 2 Terminated
23 enrolled
Multicenter Randomized Controlled Trial Adjuvant Chemotherapy vs Observation in pStage Ib Lung Adenocarcinoma
Phase 3 Unknown
1,012 enrolled
Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer
Phase 1 Terminated
8 enrolled
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
Phase 3 Completed
3,300 enrolled
Study of Oral Vinorelbine and Erlotinib in Non-Small Cell Lung Cancer
Phase 1 Completed
30 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer
Phase 1/2 Terminated
36 enrolled
Carboplatin Plus Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Phase 1/2 Completed
Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery
Phase 2 Completed
21 enrolled
Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer
Phase 3 Completed
200 enrolled
VINCR
Phase 2 Completed
60 enrolled
Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer
Phase 3 Completed
180 enrolled